Bioproduction
/
Eastern Norway

Medistim Asa
INTRA OPERATIVE QUALITY CONTROL APPLICATIONS FOR CARDIAC & VASCULAR SURGEONS

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 154.33
    Operating profit: 36.882
    Operating profit before tax: 47.815
    Total assets: 197.109
    Total equity:117.845
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Øyvin Anders Brøymer

    Board Members:
    Lars Rønn
    Siri Fürst
    Tove Raanes

    General Manager:
    Kari Eian Krogstad

    Subsidiary companies:
    Largest shareholders:
    N/A
    Medicines,